Transfusion of RhD-Positive Blood Components to Serologic RhD-Negative Patients-Review of Current Literature: An Opinion
10.17945/kjbt.2022.33.3.1 7 8
- Author:
Soo Ho YU
1
;
In Hwa JEONG
;
Duck CHO
Author Information
1. Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- Publication Type:Letters to the Editor
- From:Korean Journal of Blood Transfusion
2022;33(3):178-181
- CountryRepublic of Korea
- Language:English
-
Abstract:
Among RhD variants, it is considered safe to transfuse RhD positive blood to “Asia-type” DEL and weak D type 1, 2, and 3 recipients. However, transfusing RhD-positive blood cells in the “Asia-type” DEL, (serologically typed as RhD-negative), is still a cause for concern among clinicians. Here, the safety of transfusing RhD-positive blood components to “Asia-type” DEL recipients is re-emphasized by reviewing previously published literature.
